Sodium Methanesulfinate CAS 20277-69-4 Tsarkake> 96.0% Babban Tsabta
Shanghai Ruifu Chemical Co., Ltd. shine babban kamfani na Sodium Methanesulfinate (CAS: 20277-69-4) tare da inganci mai kyau.Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi sodium Methanesulfinate,Please contact: alvin@ruifuchem.com
Sunan Sinadari | Sodium Methanesulfinate |
Makamantu | Methanesulfinic acid sodium gishiri |
Lambar CAS | 20277-69-4 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: CH5NaO2S |
Nauyin Kwayoyin Halitta | 104.1 |
Matsayin narkewa | 222.0 ~ 226.0 ℃ ( Dec.) (lit.) |
Ruwan Solubility | Mai narkewa a cikin Ruwa |
M | Ƙwararren iska & Hygroscopic |
COA & MSDS | Akwai |
Asalin | Shanghai, China |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari ko Kashe-White Crystal Powder |
Tsafta | > 96.0% |
Asarar bushewa | <1.00% |
Infrared Spectrum | Yayi daidai da Tsarin |
Abubuwan da aka bayar na Proton NMR Spectrum | Yayi daidai da Tsarin |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Magunguna;Tsarin Halitta |
Alamomin haɗari | Xn - Mai cutarwa |
Lambobin haɗari | R22 - Yana cutarwa idan an haɗiye shi |
R20/21/22 - Cutarwa ta hanyar shakarwa, a cikin hulɗa da fata kuma idan an haɗiye shi. | |
Bayanin Tsaro | S36/37 - Sanya tufafin kariya da safar hannu masu dacewa. |
S24/25 - Guji hulɗa da fata da idanu. | |
ID na UN | 2811 |
WGK Jamus | 3 |
Rukunin tattarawa | III |
Shanghai Ruifu Chemical Co., Ltd. kasuwanci wadata Sodium Methanesulfinate (CAS: 20277-69-4).Yana da mahimmancin magungunan magunguna, wanda za'a iya amfani dashi a cikin samar da API (CAS 231277-92-2) da (CAS 388082-78-8) API ko wasu masu tsaka-tsaki.(CAS 388082-78-8), wani sabon memba na 4-anilinoquinazoline class of RTK inhibitors (RTKIs), an kaddamar da shi azaman maganin maganin ciwon nono.Yana da alaƙa biyu don EGFR da HER2 tyrosine kinases.An nuna shi a hade tare da Capecitabine don kula da marasa lafiya da ciwon nono mai ci gaba ko metastatic wanda ciwace-ciwacen su ya wuce HER2 kuma waɗanda suka karbi maganin farko ciki har da anthracycline, haraji, da trastuzumab.